LAUSR

Metabolic Interventions in Tumor Immunity: Focus on Dual Pathway Inhibitors

Sign Up to like & get
recommendations!
2 Published in 2023 at "Cancers"

DOI: 10.3390/cancers15072043

Abstract: Simple Summary Metabolic reprogramming is one of tumor and immune cells’ most significant metabolic alterations. Moreover, metabolic-related signaling pathways, such as phosphoinositide 3-kinases (PI3Ks), the mammalian target of rapamycin (mTOR), can induce growth, proliferation, and… read more here.

Keywords: metabolic interventions; dual pathway; metabolic reprogramming; pathway inhibitors ... See more keywords